Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Pilapitiya D, Lee WS, Vu MN, Kelly A, et al. Vaccine 2024;46:126668.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pilapitiya D, Lee WS, Vu MN, Kelly A, et al. Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Vaccine 2024;46:126668.
PMID: 39740385